Gly482Ser polymorphism of the coactivator-1α of the activated receptor of peroxisome γ proliferation in individuals from Maracaibo, Venezuela;Polimorfismo Gly482Ser del gen coactivador-1α del receptor activado de proliferación de los peroxisomas γ en individuos de la ciudad de Maracaibo, estado Zulia, Venezuela. Estudio preliminar

Investigacion Clinica

Volumn 50, Issue 3, 2009, Pages 285-294

  Zambrano, Mariana ^a   Fernández, Erika ^b   López, Maciel ^a   Rangel, Annell ^a   De Romero, Pilar ^a   Fernández, Virginia ^b   Morales, Luz Marina ^b   Molero Conejo, Emperatriz ^b   Connell, Lissett ^b   Raleigh, Xiomara ^b   Aranguren Mendez, José ^a  

^a UNIVERSIDAD DEL ZULIA   (Venezuela)

^b UNIVERSIDAD DEL ZULIA   (Venezuela)

Author keywords

Insulin resistance; PGC 1; Polymorphism Gly482Ser

Indexed keywords

GLUCOSE; GLYCINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1BETA; SERINE; TRIACYLGLYCEROL; CHOLESTEROL; HEAT SHOCK PROTEIN; PPARGC1A PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ADULT; ALLELE; ANTHROPOMETRY; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; VENEZUELA; AMINO ACID SUBSTITUTION; BLOOD; COMPARATIVE STUDY; GENETICS; HYPERTRIGLYCERIDEMIA; MIDDLE AGED; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICS; URBAN POPULATION;

ADULT; AMINO ACID SUBSTITUTION; BLOOD GLUCOSE; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; FEMALE; GENOTYPE; HEAT-SHOCK PROTEINS; HUMANS; HYPERTRIGLYCERIDEMIA; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANSCRIPTION FACTORS; TRIGLYCERIDES; URBAN POPULATION; VENEZUELA;

EID: 73949102079     PISSN: 05355133     EISSN: 05355133     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. American Heart Association, 2007. Resistencia a la Insulina. Disponible en www.americanheart.org
2. González E, Pascual C, Laclaustra J, Casanovas L. Síndrome metabólico y diabetes mellitus. Rev Esp Cardiol 2005; 5:30-37.
3. Sociedad Española de Diabetes. Resistencia a la insulina y su implicación en múltiples factores de riego asociados a diabetes tipo 2. Med Clín 2002; 119:458-463.
4. Fanelli M, Filippi E, Sentinelli F, Romeo S, Fallarino M, Buzzetti R, Leonetti F, Baroni MG. The Gly482Ser missense mutation of the peroxisome proliferator-activated receptor gamma coactivator-1alpha (PGC-1alpha) gene associates with reduced insulin sensitivity in normal and glucose-intolerant obese subjects. Dis Markers 2005; 21:175-180.
5. Rodríguez M. Diferenciación adipocitaria y factores reguladores de la biogénesis mitocondrial efectos de los fármacos antirretroviral. España: Universidad de Barcelona; 2004.
6. Cruz M, García M, López E, Valladares A, Sánchez R, Wacher N, Aguilar Gaytán, Kumare J. Genes candidatos como posibles marcadores de susceptibilidad a diabetes tipo 2. REB 2005; 24:81-86.
7. Kunej T, Globocnik P, Dovc P, Peterlin B, Petrovic D. A Gly482Ser polymorphism of the peroxisome proliferator activated receptor γ coactivator -1 (PGC-1) gene is associated with type 2 diabetes in caucasians. Folia Biol (Praha) 2004; 50:157-158.
8. Vohl M, Houde A, Lebel S, Hould FS, Marceau P. Effects of the peroxisome proliferator-activated receptor gamma coactivator - 1 Gly482Ser variant on features of the metabolic syndrome, Mol Genet Metab. 2005; 86: 600-606.
9. Nitz I, Ewert A, Klapper M. Dormy T. Analysis of PGC-1 alfa variant Gly482Ser and Thr612Met concerning their PPARs function. Biochem Biophys Res Commun 2007; 353:481-486.
10. Muller L, Bogardus C, Pedersen O, Baier L. A Gly482Ser missense mutation in the peroxisome proliferator activated receptor γ coactivator-1 is associated with altered lipid oxidation and early insulin secretion in Pima Indians. Diabetes 2003; 52:895-898.
11. Andersen G, Hansen S, Gharani N, Frailing T, Owen K, Sampson M, Ellard S, Walkerd M, Hitman G, Hattersley A, Mc-Carthy M, Pedersen O. A common Gly482Ser Polymorphism of PGC-1 is associated with type 2 diabetes mellitus in two European populations. Diabetes 2002; 51: A49-A50.
12. Lucia A, Gómez-Gallego F, Barroso I, Rabadán M, Bandrés F, San Juan A, Chicharro J, Ekelund U, Brage S, Earnest C, Warcham N, Franks P. PPARGC1A genotype (Gly482Ser) predicts exceptional endurance capacity in European men. J Appl Physiol 2005; 99: 344-348.
13. Ambye L, Rasmussen S, Fenger M, Jorgensen T, Borch-Johhsen K, Madsbad S, Urhammer S. Studies of the Gly482Ser polymorphism of the peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α) gene in Danish subjects with the metabolic syndrome. Diabetes Res Clin Pract 2004; 67:175-179.
14. Barroso I, Luan J, Sandhu M, Franks P, Crowley V, Schafer A, O'Rahilly S, Warcham N. Meta-analysis of the Gly482Ser variant in PPARGC1A in type 2 diabetes and related phenotypes. Diabetologia. 2006; 49: 501-505.
15. Lai C, Tucker K, Parnell L, Adiconis X, Garcia-Bailo B, Griffith J, Meydani M, Ordovas J. PPARGC1A (PGC1A) Variation associated with DNA damage, diabetes and cardiovascular diseases: the Boston Puerto Rican Health Study. Diabetes 2008; 57: 809-816.
16. Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R. Homeostasis model assessment: Insulin resistance and beta-cell funtion from fasting plasma glucose and insulin concentrations in man. Diabetología 1985; 28:412-419.
17. Fernández V, Clavell E, Villasmil J, Calmón G, Raleigh X, Morales LM, Campos G, Ryder E, Silva E. Niveles básales de insulina en una población del estado Zulia, Venezuela. Invest Clín 2006; 47:167-177.
18. Friedewald W, Levy R, Fredrickson D. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18:499-502.
19. Ausubel F, Brenr R, Kingston R, Moore D, Seidman J, Smith J. Preparation of genomic DNA. Phenol extraction and concentration of DNA from aqueos solutions. In: Shart protocols in molecular biology a Compendium of methods from current protocols in molecular biology. Ed. Reene Publishing Associated and Willey-Interscience. 1989.
20. Miller A, Oykes D, Polesky H. A simple satting out procedure for extracting from human nucleated cells. Nucleic Acids Res 1988; 16:12-15.
21. World Heart Organization Obesity: preventing and managing the global epidemic of obesity. R word consultation of obesity. Geneva 3-5 june 1997.
22. Standards of medical care for patients with diabetes mellitus diabetes care http://care.diabetesjournals.org/cgi/reprint/30/suppl-1/S4
23. Stumvoll M, Fritsche A, t'Hart L, Machann C, Thamer O Tschriter T, Van Haeftens S, Jacob J, Dekker J, Maassen F, Schick R, Heine H, Haring T. The Gly482ser variant in the peroxisome proliferator- activated receptor gamma coactivator-1 is not associated with diabetes-related traits in non diabetic German and Dutch population. Exp Clin Endocrinol Diabetes 2004; 112:253-257.
24. Lacquemant M, Chikri P, Boutin C, Samson P, Froguel P. No association between the G482S polymorphism of the proliferator activated receptor- gamma coactivator-1 (PGC1) gene and type II diabetes in french Caucasias. Diabetologia.2002; 45:602-603.
25. Hara K, Tobe K, Okada T, Kadowaki H, Akanuma Y, Ito C, Kimura S, Kawaoki T. A genetic variation in the PGC1 gene could confer insulin resistance and suceptibility to type II diabetes. Diabetología 2002; 45:740-743.
26. Nelson T, Fingerlin T, Moss L, Barmada M, Ferrell R, Norris J. The peroxisome proliferator-activated receptor gamma coactivator-1 alpha Gene (PGC-1) is not associated with Type 2 Diabetes Mellitus or body mass index among hispanic and non hispanic whites from colorado. Exp Clin Endocrinol Diabetes 2007; 115:268-275.
27. Ek J, Andersen G, Urhammer S, Gaede P, Drivsholm T, Borch-Johnsen K, Pedersen O. Mutation analisys of peroxisome proliferator-activated receptor-γ coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to type II diabetes mellitus. Diabetologia 2001; 44: 2220-2226.
28. Andrulionyte L, Zacharova J, Chiasson Jl. Common polymorphism of the PPARgamma2 (pro12ala) and PGC-1 alpha (Gly482Ser) genes are associated with the conversion from impaired glucose tolerance to type 2 diabetes in the STOPNIDDM trial. Diabetologia 2004; 47:2176-2184.
29. Lucia A, Gomez-Gallego F, Barroso I. PPARGC1 genotype (Gly482Ser) predicts exceptional endurance capacity in European males. J Appl Physiol 2005; 99:344-348.
30. Hammarstedt A, Jansson P, Wesslau X, Smith Y. Reduced expression of PGC-1 and insulin- signalling molecules in adipose tissue is associated with insulin resistance. Biochem Biophys Res Commun 2003; 301:578-583.
31. Sniderma A, Scantlebury T, Cianflone K. Hypertriglyceridemic hyperapoB: the unappreciated atherogenic dyslipoproteinemia in type 2 diabetes mellitus. Ann Intern Med 2001; 135:447-459.
32. Rizzo M, Berneis K. Low-density lipoprotein size and cardiovascular risk assessment. J Med 2006; 99:1-14.
33. Krayenbuehla P, Wieslib P, Schmidb C, Lehmannb R, Spinasb G. Insulin sensitivity in type 2 diabetes is closely associated with LDL particle. Swiss Med Wkly 2008; 138:275-280.